DYT-PRKRA中黑质纹状体变性的影像学证据。
Imaging Evidence of Nigrostriatal Degeneration in DYT-PRKRA.
作者信息
Pinto Maria João, Oliveira Ana, Rosas Maria José, Massano João
机构信息
Movement Disorders and Functional Surgery Unit, Department of Neurology, Centro Hospitalar Universitário de São João Porto Portugal.
Department of Clinical Neurosciences and Mental Health, Faculty of Medicine University of Porto Porto Portugal.
出版信息
Mov Disord Clin Pract. 2020 Apr 6;7(4):472-474. doi: 10.1002/mdc3.12941. eCollection 2020 May.
相似文献
1
Imaging Evidence of Nigrostriatal Degeneration in DYT-PRKRA.
Mov Disord Clin Pract. 2020 Apr 6;7(4):472-474. doi: 10.1002/mdc3.12941. eCollection 2020 May.
2
Reversible Acute Parkinsonism and Unusual Neuroimaging Findings in Systemic Lupus Erythematosus.
Mov Disord Clin Pract. 2020 Apr 7;7(4):459-461. doi: 10.1002/mdc3.12943. eCollection 2020 May.
3
Ataxia Telangiectasia Gene Mutation in Isolated Segmental Dystonia Without Ataxia and Telangiectasia.
Mov Disord Clin Pract. 2017 Dec 3;5(1):89-91. doi: 10.1002/mdc3.12564. eCollection 2018 Jan-Feb.
4
Is it Useful to Classify Progressive Supranuclear Palsy and Corticobasal Degeneration as Different Disorders? No.
Mov Disord Clin Pract. 2018 Mar 6;5(2):141-144. doi: 10.1002/mdc3.12582. eCollection 2018 Mar-Apr.
5
Delayed Hypersensitivity Reaction to OnabotulinumtoxinA.
Mov Disord Clin Pract. 2018 Mar 9;5(3):321-322. doi: 10.1002/mdc3.12575. eCollection 2018 May-Jun.
6
Episodic Ataxia Type 1 (K-channelopathy) Manifesting as Paroxysmal Nonkinesogenic Dyskinesia: Expanding the Phenotype.
Mov Disord Clin Pract. 2017 Jul 31;4(5):784-786. doi: 10.1002/mdc3.12518. eCollection 2017 Sep-Oct.
7
The prevalence of PRKRA mutations in idiopathic dystonia.
Parkinsonism Relat Disord. 2018 Mar;48:93-96. doi: 10.1016/j.parkreldis.2017.12.015. Epub 2017 Dec 13.
8
Pseudogene Complicating the Diagnosis of Young-Onset Dystonia Due to Gene Disease-Causing Variants (DYT-).
Mov Disord Clin Pract. 2022 Mar 4;9(5):703-706. doi: 10.1002/mdc3.13426. eCollection 2022 Jul.
9
DYT16 revisited: exome sequencing identifies PRKRA mutations in a European dystonia family.
Mov Disord. 2014 Oct;29(12):1504-10. doi: 10.1002/mds.25981. Epub 2014 Aug 20.
10
Parkinsonism in diseases predominantly presenting with dystonia.
Int Rev Neurobiol. 2019;149:307-326. doi: 10.1016/bs.irn.2019.10.007. Epub 2019 Nov 21.
引用本文的文献
1
Luteolin protects DYT- cells from apoptosis by suppressing PKR activation.
Front Pharmacol. 2023 Feb 15;14:1118725. doi: 10.3389/fphar.2023.1118725. eCollection 2023.
本文引用的文献
1
The prevalence of PRKRA mutations in idiopathic dystonia.
Parkinsonism Relat Disord. 2018 Mar;48:93-96. doi: 10.1016/j.parkreldis.2017.12.015. Epub 2017 Dec 13.
2
PRKRA Mutation Causing Early-Onset Generalized Dystonia-Parkinsonism (DYT16) in an Italian Family.
Mov Disord. 2016 May;31(5):765-7. doi: 10.1002/mds.26583. Epub 2016 Mar 17.
3
Altered activation of protein kinase PKR and enhanced apoptosis in dystonia cells carrying a mutation in PKR activator protein PACT.
J Biol Chem. 2015 Sep 11;290(37):22543-57. doi: 10.1074/jbc.M115.669408. Epub 2015 Jul 31.
4
DYT16 revisited: exome sequencing identifies PRKRA mutations in a European dystonia family.
Mov Disord. 2014 Oct;29(12):1504-10. doi: 10.1002/mds.25981. Epub 2014 Aug 20.
5
Phenomenology and classification of dystonia: a consensus update.
Mov Disord. 2013 Jun 15;28(7):863-73. doi: 10.1002/mds.25475. Epub 2013 May 6.
6
DYT16, a novel young-onset dystonia-parkinsonism disorder: identification of a segregating mutation in the stress-response protein PRKRA.
Lancet Neurol. 2008 Mar;7(3):207-15. doi: 10.1016/S1474-4422(08)70022-X. Epub 2008 Feb 1.
Zotero 插件